阳虚体质易发抑郁症低动力症状的“微生物-肠-脑”轴调控机制研究

注册号:

Registration number:

ITMCTR2200006669

最近更新日期:

Date of Last Refreshed on:

2022-09-30

注册时间:

Date of Registration:

2022-09-30

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

阳虚体质易发抑郁症低动力症状的“微生物-肠-脑”轴调控机制研究

Public title:

Study on the regulation mechanism of

注册题目简写:

English Acronym:

研究课题的正式科学名称:

阳虚体质易发抑郁症低动力症状的“微生物-肠-脑”轴调控机制研究

Scientific title:

Study on the regulation mechanism of

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2200064200 ; ChiMCTR2200006669

申请注册联系人:

李英帅

研究负责人:

李英帅

Applicant:

Yingshuai Li

Study leader:

Yingshuai Li

申请注册联系人电话:

Applicant telephone:

13681410020

研究负责人电话:

Study leader's telephone:

13681410020

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liyingshuai2013@163.com

研究负责人电子邮件:

Study leader's E-mail:

liyingshuai2013@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

北京市朝阳区北三环东路11号

研究负责人通讯地址:

北京市朝阳区北三环东路11号

Applicant address:

11 North Third Ring East Road, Chaoyang District, Beijing

Study leader's address:

11 North Third Ring East Road, Chaoyang District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京中医药大学

Applicant's institution:

Beijing University of traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2022BZYLL0608

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

北京中医药大学医学伦理委员会

Name of the ethic committee:

Ethics Committee of Beijing University of Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2022/6/27 0:00:00

伦理委员会联系人:

秦灵灵

Contact Name of the ethic committee:

Lingling Qin

伦理委员会联系地址:

北京市朝阳区北三环东路11号

Contact Address of the ethic committee:

11 North Third Ring East Road, Chaoyang District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京中医药大学

Primary sponsor:

Beijing University of traditional Chinese Medicine

研究实施负责(组长)单位地址:

北京市朝阳区北三环东路11号

Primary sponsor's address:

11 North Third Ring East Road, Chaoyang District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京中医药大学

具体地址:

北京市朝阳区北三环东路11号

Institution
hospital:

Beijing University of traditional Chinese Medicine

Address:

11 North Third Ring East Road, Chaoyang District, Beijing

经费或物资来源:

国家自然科学基金资助面上项目(82074291)

Source(s) of funding:

General program supported by National Natural Science Foundation of China (82074291)

研究疾病:

轻中度抑郁障碍

研究疾病代码:

Target disease:

Mild to moderate depressive disorder

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

以平和体质健康人群为对照,采用宏基因组学和代谢组学研究方法,通过相关分析,识别与低动力症状相关的阳虚体质特征功能菌群及代谢通路,初步揭示阳虚体质易发抑郁症低动力症状的“微生物-肠-脑”轴调控机制,为从调理体质入手防治抑郁症低动力症状提供新的思路。

Objectives of Study:

Taking the healthy people with mild constitution as the control, we identify the functional flora and metabolic pathways of Yang deficiency constitution related to low dynamic symptoms by using metagenomics and metabonomics research methods, and preliminarily reveal the "microbiological gut brain" axis regulation mechanism of Yang deficiency constitution prone to depression low dynamic symptoms, which provides a new idea for preventing and treating depression low dynamic symptoms from regulating constitution.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)汉族,年龄18~60周岁,男女不限; (2)符合平和体质/阳虚体质判定标准的单纯体质或兼夹体质者; (3)17项汉密尔顿抑郁量表(HAMD-17)评分<7分; (4)阳虚体质者中偏肾阳不足者; (5)常规体检正常或无其他明确疾病诊断; (6)近2年在京居住; (7)知晓并理解本研究的内容,自愿签署知情同意书。

Inclusion criteria

(1) Han nationality, aged from 18 to 60 years old, male or female; (2) Those with simple constitution or combined constitution that meet the criteria of mild constitution / yang deficiency constitution; (3) 17 items Hamilton Depression Scale (HAMD-17) score < 7; (4) Among those with Yang deficiency constitution, those with kidney yang deficiency; (5) Normal routine physical examination or no other clear disease diagnosis; (6) Living in Beijing in recent 2 years; (7) Know and understand the contents of this study, and voluntarily sign the informed consent form.

排除标准:

(1)兼夹其他体质超过两种者; (2)特殊的兼夹体质者:平和体质与阳虚体质倾向、气郁体质倾向兼夹,阳虚体质与气郁体质兼夹; (3)近1个月内应用过糖皮质激素、抗生素、微生态调节剂、胃肠动力药者; (4)在筛选前1个月内参加过其他药物临床研究者。

Exclusion criteria:

(1) Those with more than two other constitutions; (2) Special dual Constitution: mild constitution and yang deficiency constitution tendency, qi depression constitution tendency, Yang deficiency constitution and qi depression constitution; (3) Those who have used glucocorticoids, antibiotics, microecological regulators and gastrointestinal motility drugs in the past month; (4) Those who participated in clinical research of other drugs within 1 month before screening.

研究实施时间:

Study execute time:

From 2021-01-01

To      2024-12-31

征募观察对象时间:

Recruiting time:

From 2022-10-01

To      2024-06-30

干预措施:

Interventions:

组别:

阳虚体质未病组

样本量:

50

Group:

Yang deficiency constitution without disease group

Sample size:

干预措施:

生活方式干预

干预措施代码:

Intervention:

Lifestyle intervention

Intervention code:

组别:

平和体质组

样本量:

50

Group:

Mild constitution group

Sample size:

干预措施:

生活方式干预

干预措施代码:

Intervention:

Lifestyle intervention

Intervention code:

样本总量 Total sample size : 100

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院

单位级别:

三级甲等

Institution/hospital:

Beijing Anding Hospital Affiliated to Capital Medical University

Level of the institution:

Third Grade First Class

测量指标:

Outcomes:

指标中文名:

外周血浆神经递质浓度

指标类型:

主要指标

Outcome:

Peripheral plasma neurotransmitter concentration

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

粪便16s

指标类型:

主要指标

Outcome:

Feces 16S

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

《中医体质量表》评分

指标类型:

主要指标

Outcome:

Score of TCM constitution Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疲劳量表

指标类型:

主要指标

Outcome:

FS-14

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血清非靶向代谢组

指标类型:

主要指标

Outcome:

Serum non targeted metabolome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

斯奈思-汉密尔顿快感量表

指标类型:

主要指标

Outcome:

SHAPs

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

粪便宏基因组

指标类型:

主要指标

Outcome:

Fecal metagenome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉密尔顿抑郁量表17项

指标类型:

主要指标

Outcome:

HAMD17

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

粪便代谢组

指标类型:

主要指标

Outcome:

Fecal metabolome

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁症快速评估量表QIDS-SR16

指标类型:

主要指标

Outcome:

Rapid assessment scale of depression QIDS-SR16

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

粪便

组织:

Sample Name:

feces

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 60
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由第三方使用统计软件产生随机号

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number generated by a third party using statistical software

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文发表

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

论文发表

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表、电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF、EDC

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统